• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number ASD32A
Device Problem Biocompatibility (2886)
Patient Problem Mitral Valve Insufficiency/ Regurgitation (4451)
Event Date 01/31/2023
Event Type  Injury  
Manufacturer Narrative
W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
It was reported the physician implanted a 32mm gore® cardioform asd occluder to treat an atrial septal defect on (b)(6) 2022.At the time of implant the device was well seated with no issues reported.At a follow-up, the patient presented with significant mitral regurgitation.Imaging did not confirm device interference with the valves.The device was explanted on (b)(6) 2023.At the time of surgical removal, the device appeared normal.The defect was closed with a patch and the valves appeared to line up better.The physician was not sure if the device led to the mitral regurgitation or if it was the right heart size change after defect closure.
 
Manufacturer Narrative
H6: added code b15 imaging evaluation: echocardiographic interrogation revealed a moderate size posterior inferior atrial septal defect with some regurgitation at the mitral valve.The defect was measured around 1.22cm, 1.37cm, and 1.46cm respectively and was surrounded with good rims suitable for closure.Fluoroscopic images demonstrated a successful implant with the 32mm gore cardioform asd occluder to close the atrial septal defect.The left and right discs were conformed symmetrically with good separation between the left and right disc over the defect.There were no echocardiographic images available to confirm the final position of the occluder, but it was noted that the occluder was well seated with no issues reported.At discharge, a radiographic chest x ray demonstrated the occluder remained in good position.During the latest visit, it was reported on echo that there was significant regurgitation at the mitral valve.Due to the finding, the occluder was removed and the atrial septum was surgically repaired.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM ASD OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
marci stewart
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key16309082
MDR Text Key308912099
Report Number2017233-2023-03690
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00733132636495
UDI-Public00733132636495
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/06/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberASD32A
Device Catalogue NumberASD32A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/21/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age4 YR
Patient Weight16 KG
-
-